PRIMARY AND METASTATIC MUCINOUS OVARIAN CANCER. DIAGNOSTIC DIFFICULTIES AND NEWDEVELOPMENTS IN TREATMENT
- Authors: Kedrova AG1, Shablovsky ОR1, Zabozlaev FG1, Nechaeva ОE2, Krasilnikov SE3, Maksimenko TA4, Gerasimov AA3
-
Affiliations:
- Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий ФМБА России
- ФНКЦ ФМБА России
- Новосибирский областной клинический онкологический диспансер
- Алтайский краевой онкологический диспансер
- Issue: Vol 6, No 2 (2015)
- Pages: 5-14
- Section: Articles
- URL: https://journals.rcsi.science/clinpractice/article/view/8326
- DOI: https://doi.org/10.17816/clinpract625-14
- ID: 8326
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
A G Kedrova
Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий ФМБА России
Email: kedrova.anna@gmail.com
д.м.н., профессор, зав. онкологическим отделением ФНКЦ ФМБА России
О R Shablovsky
Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий ФМБА Россиизаместитель главного врача по хирургии ФНКЦ ФМБА России
F G Zabozlaev
Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий ФМБА Россиизав. патологоанатомическим отделением ФНКЦ ФМБА России
О E Nechaeva
ФНКЦ ФМБА Россииврач ультразвуковой диагностики ФНКЦ ФМБА России
S E Krasilnikov
Новосибирский областной клинический онкологический диспансерзав. отделением онкогинекологии Новосибирского областного клинического онкологического диспансера
T A Maksimenko
Алтайский краевой онкологический диспансерзав. отделением гинекологии Алтайского краевого онкологического диспансера
A A Gerasimov
Новосибирский областной клинический онкологический диспансер
References
- Горелова И.А. Муцинозные опухоли яичников различного потенциала злокачественности. Автореф. дис.. канд.мед.наук. М., 2008.
- Yamao K, Yanagisawa A, Takahashi K et al. Clinicopathological features and prognosis of mucinous cystic neoplasm with ovarian-type stroma: A Multi-Institutional Study of the Japan Pancreas Society. Pancreas. 2011 Jan;40(1):67-71. doi: 10.1097/ MPA.0b013e3181f749d3.
- Ongom P.A., Odida M., Lukande R., et.al. Metastatic colorectal carcinoma mimicking primary ovarian carcinoma presenting as ‘Giant’ ovarian tumors in an individual with probable Lynch syndrome. J Med Case Rep. 2013; 7 (158).
- Benedix F, Kube R, Meyer F, et al. Colon/Rectum Carcinomas (Primary Tumor) Study Group. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum. 2010;53(1):57-64.
- Fujiwara A, Noura S, Ohue M, Shingai T, et.al. Significance of the resection of ovarian metastasis from colorectal cancers. J Surg Oncol 2010, 102(6):582-87.
- Kanemitsu Y, Kato T, Hirai T et al. Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum 2003;46:160-67.
- NCCN Guidelines Mucinous tumors of ovaries. Version 3.2014 www.nccn.org/patients
- Rouzbahman M., Runjan Chetty R. Mucinous tumours of appendix and ovary: an overview and evaluation of current practice. J Clin Pathol 2014;67:193-97.
- Tang L, Yang J, Ng SK, Rodriguez N. Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer. Eur J Cancer. 2010 Jan; 46(1): 170-9.
- Morice P., et al. Borderline ovarian tumors: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence The lancet Oncol. 2012; 13; p e103-e115.
- Bosman FT, Carneiro F, Hruban RH, (Eds.) WHO Classification of Tumours of the Digestive System. 4th Edition, International Agency for Research on Cancer, Lyon 2010.
- Longacre T.A., Prat J., Bell D.A., et.al. Mucinous tumours. WHO Classification of Tumours of Female Reproductive Organs. 4th Edition, Edited by Robert J. Kurman. Lyon 2014, pp. 25-29.
- Verhulst J, Ferdinande L, Demetter P, et. al. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis. J Clin Pathol. 2012; 65(5): 381-88.
- Bridda A, Padoan I, Mencarelli R, et.al.// Peritoneal mesothelioma: a review. Med Gen Med 2007, 9:32.
- Feldman AL, Libutti SK, PingPank JF, et.al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 2003, 21:4560-66.
- Enomoto T, Weghorst CM, Inoue M, (1991). K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Am J Pathol 139: 777-85.
- Garrett AP, Lee KR, Colitti CR, Muto MG, Berkowitz RS, Mok SC. K-ras mutation may be an early event in mucinous ovarian tumorigenesis. Int J Gynecol Pathol 2001; 20: 244-51.
- Kondi-Pafiti A, Kairi-Vasilatou E, lavazzo C, et.al. Metastatic neoplasms of the ovaries: a clinico-pathological study of 97 cases. Arch Gynecol Obstet 2011, 284:1283-88.
- Trial GOG 241. GCIG Intergroup multicentre trial of open label carboplatin and paclitaxel +/-beva- cizumab compared with oxaliplatin and capecitabine +/-bevacizumab as first line chemotherapy in patients with mucinous Epithelial Ovarian Cancer (mEOC); Japanese Gynecologic Oncology Group 3017. Carboplatin/ paclitaxel versus carboplatin/ irinotecan.
- Randomized clinical trials of intraperitoneal chemotherapy for advanced stage epithelial ovarian cancer GOG 104/Alberts, 1996 GOG 114/Markman, 2001 GOG 172/Armstrong, 2006 GOG 252.